CBTp vs medication: the wrong question, with a useful answer

There is no question we are asked more often than this one: can my CBT replace my medication? The internet is full of people offering both directions of bad advice — that medication is unnecessary if therapy is good enough, or that therapy is a waste of time and only the drugs matter. The honest answer is more interesting than either, and it has shifted in the last decade as the evidence base has grown.

What we actually know

Three lines of evidence inform the question.

1. Combined treatment outperforms either alone

Across virtually every meta-analysis, combining antipsychotic medication with CBTp produces better outcomes than either treatment by itself for positive symptoms, distress, and functioning. The two effects are largely additive, with some evidence of synergy in patients with persistent symptoms despite medication.

2. Antipsychotics alone outperform CBT alone for severe positive symptoms

The best estimates of effect size on positive symptoms — about 0.4 for antipsychotics, 0.2 to 0.4 for CBTp — favour medication, particularly in acute episodes. For acute psychosis with severe agitation, disorganisation, or risk, antipsychotic medication is the first-line intervention recommended by every major guideline including NICE CG178 and the APA.

3. CBT alone has been formally tested in a specific population

The most important trial here is the MRC-funded FOCUS study (Morrison et al., Lancet Psychiatry 2018), which randomised people with schizophrenia who had declined or could not tolerate antipsychotic medication to either CBT alone or treatment as usual. CBT produced significant reductions in symptoms and distress over 9 months. It did not produce results equivalent to those typically seen with combined medication-plus-CBT, but it demonstrated that CBT alone is not inert in this population.

The lead author, Anthony Morrison, has been careful to say that FOCUS does not show CBT is "as good as" medication; it shows that for patients who will not take medication, CBT is better than nothing.

Why the question is often the wrong one

Framing the choice as either-or obscures the real decisions. A more useful set of questions:

• What are your goals? Symptom remission, return to work, reduced distress, fewer hospitalisations?
• Where are you in the course of the illness — first episode, established, treatment-resistant?
• What side effects have you experienced or are you most worried about?
• What other supports do you have — family, supported employment, peer support?
• Is full medication discontinuation a realistic possibility, or is the question really about reducing dose?

When patients ask about coming off medication

This is one of the most common reasons people seek CBTp. The literature on antipsychotic discontinuation suggests:

• Relapse rates after discontinuation are high — meta-analyses (Leucht et al., Lancet 2012) suggest 70 to 80% relapse within two years
• Slow tapers reduce risk compared to abrupt stops
• A subset of patients, particularly after first episode and with sustained remission, can sometimes manage on lower doses or off medication
• Predictors of doing well off medication include shorter illness duration, milder index episode, and strong psychosocial supports

If discontinuation is the goal, CBTp is one of the supports that can make it more viable — but the decision needs to be made with a prescriber, with a relapse plan, and with the recognition that returning to medication if symptoms come back is not failure, it is good care. See our piece on antipsychotic discontinuation.

Special populations

First-episode psychosis

Several trials (including the OPUS and EDIE-2 studies) have tested whether CBT plus low-dose medication can produce comparable outcomes to standard care. Results are mixed but generally support combined treatment as the most reliable approach.

Treatment-resistant schizophrenia

For patients who have not responded to two adequate trials of antipsychotic medication, the next step is usually a trial of clozapine. CBTp can be added but is not a substitute for the clozapine consideration.

People who cannot tolerate medication

For patients with severe akathisia, weight gain, sedation, or other intolerances, CBT alone may be a reasonable bridge while alternative medications are considered. FOCUS is the cleanest evidence for this approach.

Attenuated or "ultra-high-risk" symptoms

For people who have not yet had a full psychotic episode but show prodromal symptoms, NICE specifically recommends CBT rather than antipsychotic medication as first-line. This is the one population where the evidence clearly favours therapy first.

Why this conversation needs honesty

Patients sometimes seek out clinicians who promise that CBT can replace medication, and end up relapsing into severe episodes. Others stay on antipsychotics they could have safely reduced because no one ever discussed the possibility. Both outcomes reflect a failure of honest collaborative care.

The right framing

For most people with schizophrenia the most useful question is not "medication or therapy?" but "what combination, at what dose, with what supports, gets me closest to the life I want?" Both medication and CBTp belong in the toolkit. The proportions vary by person and by stage of illness, and they are not fixed for life.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.